3,3,3-Trifluoropropionic anhydride, 90.0%, 1g

4'-Bromoacetophenone, 99.0%, 100g

1H-Imidazole-4-carbaldehyde, 95.0%, 1g

ethyl 2-hydroxy-4-(2-nitrophenyl)-4-oxobut-2-enoate, 98%, 5g

4-Bromonicotinic acid, 98.0%, 5g

ethyl 6-phenylimidazo[2,1-b][1,3]thiazole-3-carboxylate, 250mg

4-(4-Chloro-phenyl)-5-(4-trifluoromethoxy-phenyl)-4H-[1,2,4]triazole-3-thiol, 250mg

N1-Cyclohexylpropane-1,3-diamine, 95.0%, 1g

3-tert-Butyl-1-phenyl-1H-pyrazol-5-amine, 95.0%, 1g

2-(4-Fluorophenyl)thiophene>95.0%(GC)5g

Bis(tridecafluoro-1,1,2,2-tetrahydrooctyl)tetra-methyldisiloxane, 1g

bis(Neodecanoate)tin, 50g

GC capillary column ROTI®Cap-5, 30 m, 0.32 mm, 5.00 µm, 1 Piece(s)